[company_age]44.0[/company_age][employees]11-50 employees[/employees][funding]series_unknown[/funding][description]Atlas Venture is a leading global venture capital firm specializing in life sciences and healthcare. Founded in 1989, the firm has a long and successful track record of investing in and building breakthrough biotechnology companies. Atlas Venture has a unique approach to investing, which it calls the "Atlas Model." This model is based on four key principles: 1) identifying and investing in transformative innovation; 2) building platform and product companies; 3) providing long-term partnership and support; and 4) prioritizing a collaborative, science-first, patient-centric culture. Atlas Venture has a team of experienced investors and entrepreneurs who have a deep understanding of the life sciences industry. The firm has a global presence, with offices in Boston, San Francisco, and London. Atlas Venture has invested in over 150 companies, including many that have gone on to become successful public companies or have been acquired by major pharmaceutical companies. Some of Atlas Venture's most notable investments include Alnylam Pharmaceuticals, Genzyme, and Millennium Pharmaceuticals. Atlas Venture is committed to making a positive impact on the world through its investments in life sciences and healthcare. The firm believes that its investments can help to improve the lives of patients and to create a healthier future for all.[/description][ps]Venture capital investments in life sciences and healthcare.[/ps]